Summary FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy, is a clinical stage biotechnology company which develops and commercializes antibody gene delivery technologies and gene vaccines for cancer immunotherapy and treatment of HIV. The company develops DNA based products using its patented gene delivery technology to control the progression to AIDS in HIV infected individuals. Its gene transfer unit has applications in DNA vaccination and immune therapy. The company also de...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.